Pandion Therapeutics

$61.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.56 (+0.92%) As of 5:50 PM UTC today

Why Robinhood?

You can buy or sell PAND and other stocks, options, and ETFs commission-free!

About PAND

Pandion Therapeutics Inc. Common Stock, also called Pandion Therapeutics, is clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. The firm develops Therapeutic Autoimmune reguLatOry protein (TALON) drug design and discovery platform. TALON platform employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded on December 31, 2018 and is headquartered in Watertown, MA. The listed name for PAND is Pandion Therapeutics Inc. Common Stock.

CEO
Rahul Kakkar
Employees
37
Headquarters
Watertown, Massachusetts
Founded
2018
Market Cap
772.31M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.27M
High Today
$62.80
Low Today
$60.52
Open Price
$61.73
Volume
157.01K
52 Week High
$62.80
52 Week Low
$10.28

PAND Earnings

-$10.15
-$6.77
-$3.38
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 31, After Hours

You May Also Like

RWJ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure